Biote

Irving, United States Founded: 2011 • Age: 15 yrs Listed
Hormone replacement and pellet therapy services are offered.

About Biote

Biote is a publicly listed company based in Irving (United States) founded in 2011 by Gary Donovitz. Hormone replacement and pellet therapy services are offered. The company has 217 employees. Its chief executive, as recorded, is Terry Weber. Its website biote.com draws about 71 thousand monthly visits. Biote offers products and services including Pellet Therapy and BHRT. Its focus areas include Life Sciences, Nutraceuticals Tech, Dietary Supplements and Disease Specific. Its legal entity is BIOTE MEDICAL, LLC. Its competitors include Timeline, Ponce De Leon Health and Optigenex.

Company details

Biote was founded in 2011 and is headquartered in Irving, United States. Operations focus on the healthcare sector, specifically hormone replacement therapy and bioidentical pellet insertions. Services are delivered through a network of practitioners, targeting hormone optimization for patients. Leadership includes founder Gary Donovitz and CEO Terry Weber, with activities centered in the U.S. market.

  • Headquarters Irving, United States
  • Employees 217
  • Founders Gary Donovitz
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website biote.com
  • Social LinkedIn Facebook Instagram
  • Legal Name Biote Corp.
Key Metrics
  • Annual Revenue
    $192.22 M (USD)
    -2.52
    as on Dec 31, 2025
  • Net Profit
    $27.05 M (USD)
    756.67
    as on Dec 31, 2025
  • EBITDA
    $42.79 M (USD)
    -4.83
    as on Dec 31, 2025
  • Employee Count
    217

Products & Services of Biote

Biote offers a comprehensive portfolio of products and services, including Pellet Therapy and BHRT.

Pellet Therapy
Hormone Treatment

Method for inserting hormones to optimize patient levels

BHRT
Hormone Replacement

Bioidentical therapy to address imbalance symptoms

People of Biote

58 people are tracked at Biote (21 in leadership, 6 in board & advisors, 31 in team); the tracked headcount is 217.

NameRoleGroup
Gary Donovitz
FounderLeadership
Terry Weber
CEOLeadership
Joey Lopes
Senior Vice President, Strategy And Commercial OperationsLeadership
Bob Peterson
Chief Financial OfficerLeadership
Shawn Reilly
Director Of Project And Program ManagementLeadership
Jesse Jackson
Director Of Customer ServiceLeadership
Kevin Key
Chief Digital Officer & Head of MarketingLeadership
Jennifer Schimmel
Head of Human ResourcesLeadership
Rob McKinney
Head Of Provider Training OperationsLeadership
Marybeth Conlon
VP, Business Development & General CounselLeadership
Chandra Valmikinathan
Vice President Commercial Operations And StrategyLeadership
Shaun Cowles
Senior Director, Finance & Sales OperationsLeadership
Michael Horton
Vice President Of IT Operations And Customer ServiceLeadership
Jessica Moseley
Head Of Web & CRMLeadership
Mary Puncochar
Chief Commercial Officer (cco)Leadership
Chantal Tousignant
Vp, Organizational Learning & Development And Customer SupportLeadership
John Beckel
Vice President - Strategic Planning & Provider DevelopmentLeadership
Ted Wemhoff
Director Of Digital Product DevelopmentLeadership
Cristal Givens
Director, Marketing Product DevelopmentLeadership
Bryan Ingram
Chief Technology OfficerLeadership

38 more people are available in the full profile.

Premium access

Complete people profiles for Biote

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Biote

Biote is a publicly listed company on the NASDAQ with ticker symbol BTMD in USA, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date28 Apr 2021
  • Listed onNASDAQ: BTMD
  • Listed entityBiote Corp.
  • Exchange sectorHealth services
  • ISINUS0906831039
  • Share price$1.04 (-8.77% on the day) · 2026-10-13
  • Market capitalisation$37.4M
  • Price to earnings8.6
  • EPS (diluted, trailing year)$0.12
  • Volume (last session)387,353

Financials of Biote

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025$192.2M$27.1M$42.8M
2024$197.2M$3.2M$45.0M
2023$185.4M$3.3M$46.2M
2022$165.0M-$969,000-$58.3M
2021$139.4M-$6.6M
Premium access

Detailed financial statements for Biote

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Biote

Biote has 3 listed competitors in our database. They include Timeline, Ponce De Leon Health and Optigenex.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
timeline.com2007San Francisco, United States
Clinically-tested Urolithin A supplements and skincare are developed.
pdlhealth.com2014Fernandina Beach, United States
Anti-aging nutraceutical supplements are developed and tested.
optigenex.com2002Melissa, United States
Optigenex is focused on healthy aging technology development.
Premium access

Detailed competitors of Biote

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Biote

The website of Biote (biote.com) receives about 70.7K visits a month.

  • Monthly visits
    70.7K

    ▲ 4% vs previous month

Similar websites

Websites whose visitors overlap most with Biote. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
evexias.com
100%
#480,965View details
healor.com
100%
11.5K#1,978,831View details
pellecome.com
92%
3.4K#5,288,448View details
xcelpeptides.com
xcelpeptides.com
92%
#762,615–
alphabiomedlabs.com
alphabiomedlabs.com
92%
#536,286–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for Biote

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Nutraceutical & Food-as-Medicine Platforms

3 companies that operate in the same segment as Biote (Nutraceutical & Food-as-Medicine Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Therapies for metabolic health in chronic disease patients are provided.
2014San Francisco, California, United StatesUSD 401.78 M910
Personalized gut health solutions are provided by ZOE.
2017New Castle, Pennsylvania, United StatesUSD 15 M
Machine learning-based bioinformatics solutions for health insights are provided.
2016Los Alamos, New Mexico, United StatesUSD 301.57 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Biote

Premium access

Complete news archive for Biote

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Biote

Biote was founded in 2011.

Biote is headquartered in Irving, United States. It is registered at Irving, Texas, United States.

Terry Weber is the CEO of Biote, as recorded in our data.

Biote has 217 employees.

Annual revenue of Biote is $192.22M as on Dec 31, 2025.

Biote was founded in 2011 and is headquartered in Irving, United States. Operations focus on the healthcare sector, specifically hormone replacement therapy and bioidentical pellet insertions. Services are delivered through a network of practitioners, targeting hormone optimization for patients. Leadership includes founder Gary Donovitz and CEO Terry Weber, with activities centered in the U.S. market.

Biote's top competitors include Timeline, Optigenex and Ponce De Leon Health.

Biote offers Pellet Therapy and BHRT.

Yes, Biote is publicly traded on NASDAQ under the ticker symbol BTMD.

Biote operates through Biote Medical, Llc.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available